Table 1.
Exon/intron location | Nucleotidic substitution in cDNA | Aminoacid substitution | Designation | Class | KM NADP+ (μM) | Reference |
---|---|---|---|---|---|---|
Exon 5, nt 376 | A → G | N126D | G6PD A | III | 12.97 | [29] |
Exon 4, nt 202 Exon 5, nt 376 |
G → A A → G |
V68M N126D |
G6PD A– | III | 15 | [155] |
Exon 6, nt 563 | C → T | S188F | G6PD Med | II | 2.43 | [29] |
Exon 8, nt 844 | G → C | D282H | G6PD Seattle | III | 2.4–2.8 | [29] |
Exon 11, nt 1260 | C → T | R454C | G6PD Union | II | 8.6 | [40] |
Exon 12, nt 1376 | G → T | R459L | G6PD Canton | II | 14.7 | [40] |
A lower level of enzyme activity in the erythrocytes of genetically deficient individuals might be due to a normal rate of synthesis of an enzyme of low catalytic efficiency, a decreased rate of synthesis of a normally active enzyme, an increased lability of the variant enzyme or a combined mechanism. The clinical phenotype depends on the mutation location in the 3D structure of the protein. G6PD A– is a more labile enzyme with normal rate of synthesis.